Burden of metastatic hormone-sensitive prostate cancer to identify men more likely to benefit from early docetaxel.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Gwenaelle Gravis, Jean-Marie Boher, Yu-Hui Chen, Glenn Liu, Karim Fizazi, Michael Anthony Carducci, Stephane Oudard, Florence Joly, David Frazier Jarrard, Michel Soulie, Mario A. Eisenberger, Muriel Habibian, Robert Dreicer, Jorge A. Garcia, Maha Hussain, Manish Kohli, Nicholas J. Vogelzang, Joel Picus, Robert S. DiPaola, Christopher Sweeney
Institutions: Aix-Marseille Université, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Université Paris-Sud, Institut Gustave Roussy, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Hôpital Européen Georges-Pompidou, Centre François Baclesse, UW Health University Hospital, Centre Hospitalier Universitaire de Toulouse, Hôpital Rangueil, UniCancer Group, University of Virginia, Cleveland Clinic, University of Michigan, Mayo Clinic, Comprehensive Cancer Centers of Nevada, Washington University in St. Louis, University of Kentucky
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2599338044